Cancer Incidence, Risk Factors, and Survival in a 31 Years-Old Brazilian HIV Cohort
Beatriz R. Pellegrina Soares,
Gabriela Prates,
Mariana A. Monteiro,
Rosa M. N. Marcusso,
Fernanda de Toledo Gon?alves,
Najara A. de Lima Nascimento,
Thales Poli,
Ana Paula R. Veiga,
Mauricio D. Ferreira,
Marcello M. C. Magri,
Luiz A. M. Fonseca,
Alberto J. S. Duarte,
Jorge Casseb,
Jorge Casseb,
Collaboration group,
Collaboration group,
Collaboration group,
Collaboration group
Affiliations
Beatriz R. Pellegrina Soares
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Gabriela Prates
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Mariana A. Monteiro
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Rosa M. N. Marcusso
Em?lio Ribas Institute of Infectious Diseases
Fernanda de Toledo Gon?alves
Laboratory of Immunohematology and Forensic Hematology-HCFMUSP, Department of Legal Medicine Medical Ethics and Social and Occupational Medicine of the S?o Paulo University
Najara A. de Lima Nascimento
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Thales Poli
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Ana Paula R. Veiga
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Mauricio D. Ferreira
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Marcello M. C. Magri
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Luiz A. M. Fonseca
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Alberto J. S. Duarte
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Jorge Casseb
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Jorge Casseb
Em?lio Ribas Institute of Infectious Diseases
Collaboration group
Secondary Immunodeficiencies Service (ADEE3002), Department of Dermatology of Hospital of Clinics, University of S?o Paulo Medical School-ADEE 3002/HC/FMUSP of the S?o Paulo University
Collaboration group
Em?lio Ribas Institute of Infectious Diseases
Collaboration group
Laboratory of Immunohematology and Forensic Hematology-HCFMUSP, Department of Legal Medicine Medical Ethics and Social and Occupational Medicine of the S?o Paulo University
This study aimed to report cancer incidence and mortality in a Brazilian human immunodeficiency virus (HIV) cohort of 31?years duration and compare cancer deaths with deaths due to noncancer causes. We also investigated risk factors for the development of acquired immunodeficiency syndrome (AIDS)-defining and non-AIDS-defining cancers. We searched for any information related to the diagnosis of cancer in a period ranging from 1989 to 2020. We also collected data on sociodemographic and clinical information and risk factors. Statistical analysis included parametric and nonparametric tests and the building of survival curves. We used the statistical software GraphPad software (version 9) and STATA software (version 14) for the elaboration of statistics. Fifty-five new cases of cancer occurred in a total of 677 HIV patients included in our cohort over 31?years, an incidence of 8.12%. The most important risk factors associated with cancer were smoking (p = 0.03), infection with oncoviruses like human papillomavirus (p < 0.001), and hepatitis C (p = 0.04). Eleven patients (1.6%) died from cancer. The most frequent diagnoses of fatal cancer were liver cancer and lymphoma (three cases each). The mean follow-up time of patients dying from cancer was 14?years; patients dying from noncancer causes were 24 (3.55%), and their mean follow-up time was 11?years. We had low overall mortality in our cohort of HIV patients (5.2%), mostly due to noncancer causes, which may be due to the fact that most of our patients begin follow-up asymptomatic. Cancer deaths were 31.4% of all deaths; half of those cancers were AIDS-defining.